시장보고서
상품코드
1918344

타가토스 시장 - 예측(2026-2031년)

Tagatose Market - Forecast from 2026 to 2031

발행일: | 리서치사: Knowledge Sourcing Intelligence | 페이지 정보: 영문 145 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

타가토스 시장은 2025년 2억 376만 5,000달러에서 2031년에는 2억 8,266만 8,000달러로, CAGR 5.61%로 확대할 것으로 예측되고 있습니다.

타가토스는 섭취해도 혈당 상승을 일으키지 않는 독특한 특성으로 인해 당뇨병 환자를 위한 특수 식품의 배합이 유망한 원료로 주목받고 있습니다. 미국 식품의약국(FDA)으로부터 GRAS(일반적으로 안전하다고 인정되는 물질) 인증을 받아 각종 식품 및 음료에 감미료로 사용할 수 있도록 정식으로 인정받았습니다. 감미료로서의 유용성 외에도 타가토스는 충치 위험 감소, 장내 환경 개선, 심장병 위험 감소 등 다양한 건강 효과와 관련이 있습니다. 타가토스 시장은 주로 분말과 액상 두 가지 형태로 구성되어 있으며, 제조업체에 다용도성을 제공하고 식품 및 음료 산업에서 다양한 용도의 요구를 충족시키고 있습니다.

시장 성장 촉진요인

당뇨병 환자 증가가 주요 성장 요인으로 작용하고 있습니다. 예비 인체 연구에 따르면 타가토스가 식후 혈당과 인슐린 반응을 낮추는 것으로 나타났습니다. 당뇨병의 확산은 전 세계적인 건강 문제이며, 주요 국가에서 눈에 띄는 환자 수가 보고되고 있습니다. 기존 설탕을 대체할 수 있는 잠재력과 혈당 반응에 대한 입증된 이점을 고려할 때, 타가토스는 특히 당뇨병 및 당뇨병 전단계의 식단 관리 솔루션을 찾는 사람들에게 주목할 만한 대안으로 떠오르고 있습니다.

타가토스의 건강 효과에 대한 인식이 높아지면서 시장 확대를 주도하고 있습니다. 현대 치료제의 잠재적 부작용에 대한 우려로 인해 소비자들은 D-타가토스를 생활에 도입할 경우 얻을 수 있는 잠재적 이점에 대해 더 많이 인식하고 있습니다. FDA는 D-타가토스의 건강 증진 특성을 인정하여 D-타가토스를 다양한 건강 효과를 제공하는 희귀 설탕으로 승인했습니다. 이러한 이점에는 혈당 조절 개선, 심혈관 질환 위험 감소, 충치 감수성 감소, 장내 환경 개선 등이 포함됩니다. 수많은 인체 및 동물 실험이 d-타가토스 섭취의 안전성을 지원하고 있으며, 현재까지 유해한 영향은 보고된 바 없습니다. 특히 한국, 호주, 뉴질랜드 등의 국가에서 d-타가토스가 범용 감미료로 사용되고 있으며, 이는 전 세계에서 인지도와 수요 증가에 기여하고 있습니다.

시장이 해결해야 할 과제

유망한 잠재력에도 불구하고 타가토스 시장은 가용성의 한계와 생산과 관련된 복잡한 효소 공정으로 인해 몇 가지 문제에 직면해 있습니다. 현재 타가토스는 추출 과정의 복잡성으로 인해 다른 감미료에 비해 상대적으로 비쌉니다. 유당에서 타가토스를 추출하는 데 필요한 전문적이고 다단계적인 절차가 생산 비용에 큰 영향을 미치고 있습니다. 또한 타가토스 생산의 주요 원료인 유당에 대한 의존도는 유제품 시장의 변동과 공급망의 잠재적 혼란에 대한 취약성을 초래합니다. 이러한 요인으로 인해 제조업체는 타가토스의 안정적인 공급이 어려워지고, 다양한 제품에 타가토스의 배합 가능성에 영향을 미치며, 보다 광범위한 시장 도입을 제한할 수 있습니다.

목차

제1장 개요

제2장 시장 개요

  • 시장 개요
  • 시장의 정의
  • 조사 범위
  • 시장 세분화

제3장 비즈니스 상황

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • Porter's Five Forces 분석
  • 업계 밸류체인 분석
  • 정책과 규제
  • 전략적 제안

제4장 기술 전망

제5장 타가토스 시장 : 용도별

  • 서론
  • 식품 및 음료
  • 의약품
  • 기타

제6장 타가토스 시장 : 형태별

  • 서론
  • 분말
  • 액체

제7장 타가토스 시장 : 유통 채널별

  • 서론
  • 온라인
  • 오프라인

제8장 타가토스 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 남미
    • 브라질
    • 아르헨티나
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 스페인
    • 기타
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 인도네시아
    • 태국
    • 기타

제9장 경쟁 환경과 분석

  • 주요 기업과 전략 분석
  • 시장 점유율 분석
  • 합병, 인수, 합의 및 협업
  • 경쟁 대시보드

제10장 기업 개요

  • Bonumose, Inc.
  • Damhert Nutrition NV
  • Linlu Biotechnology Co., Ltd.
  • Anhui Hegeng Biotech Engineering
  • Wuxi Jcantek Pharmaceuticals
  • Syngars Technology
  • Henan Yihengyuan Biotechnology
  • Zhejiang Yixin Pharmaceutical Co., Ltd.
  • Huaxu Pharmaceutical
  • Glentham Life Sciences
  • Clearsynth Labs
  • GLR Innovations
  • Inalco SpA
  • HSF Biotech
  • Hebei Runxuchen Trading Co., Ltd.

제11장 부록

  • 통화
  • 전제조건
  • 기준연도 및 예측연도 타임라인
  • 이해관계자에 대한 주요 이점
  • 조사 방법
  • 약어
KSA 26.02.20

Tagatose Market is projected to increase at a 5.61% CAGR, growing from USD 203.765 million in 2025 to USD 282.668 million in 2031.

Tagatose emerges as an appealing ingredient for inclusion in specialized foods for individuals with diabetes due to its unique characteristic of not causing increases in glucose blood levels upon consumption. Granted GRAS (Generally Recognized As Safe) status by the U.S. Food and Drug Administration (FDA), tagatose is officially recognized for use as a sweetener in various food and beverage products. Beyond its utility as a sweetener, tagatose has been associated with various health benefits, including reduced risk of tooth decay, improvements in gut health, and decreased risk of heart disease. The tagatose market is characterized by two primary forms-powder and liquid-offering versatility to manufacturers and catering to diverse application needs within the food and beverage industry.

Market Drivers

The rising number of diabetic cases represents a primary growth catalyst. Preliminary human studies have indicated that tagatose exhibits low postprandial blood glucose and insulin response. The prevalence of diabetes is a global health concern, with significant numbers reported in major nations. Given its potential as an alternative to traditional sugar and its demonstrated benefits in glycemic response, tagatose emerges as a noteworthy contender in the market, particularly for individuals seeking dietary management solutions for diabetes and prediabetic conditions.

Rising awareness about health benefits of tagatose is driving market expansion. Consumers are becoming more conscious of potential advantages of incorporating d-tagatose into their lifestyles, driven by concerns about potential side effects of modern therapeutic agents. Recognizing its health-promoting properties, the FDA acknowledges d-tagatose as a rare sugar offering a spectrum of health benefits. These benefits include enhanced glycemic control, reduced risk of cardiovascular disease, lowered susceptibility to tooth decay, and improvements in gut health. Numerous human and animal studies support the safety of d-tagatose consumption, with no adverse effects reported to date. Notably, d-tagatose serves as a general-purpose sweetener in countries such as Korea, Australia, and New Zealand, contributing to its increased awareness and demand globally.

Market Challenges

Despite promising potential, the tagatose market encounters several challenges stemming from limited availability and the intricate enzymatic process involved in its production. Currently, tagatose is relatively more expensive compared to other sweeteners due to complexity of its extraction process. The specialized and multi-step procedures required to extract tagatose from lactose contribute significantly to its production cost. Moreover, reliance on lactose as the primary raw material for tagatose production introduces vulnerability to fluctuations in dairy markets and potential disruptions in the supply chain. These factors pose challenges to consistent availability of tagatose for manufacturers, potentially impacting feasibility of incorporating tagatose into various products and limiting broader market adoption.

Market Segmentation

By application, the tagatose market is categorized into food and beverages, pharmaceuticals, and other sectors. Within the food and beverage domain, tagatose has gained popularity as a sought-after alternative to sugar, finding widespread use in variety of food and beverage products. In the pharmaceutical arena, tagatose is undergoing exploration as a potential ingredient in diabetic medications and oral care products. This interest is fueled by its distinguished attributes, including low glycemic index and prebiotic properties. Beyond these primary segments, tagatose finds utility in other categories as well. It may be incorporated into certain cosmetic products where its humectant properties can be beneficial. Additionally, tagatose's presence in some dietary supplements is notable, particularly in the role of a prebiotic, demonstrating its versatility across multiple application areas.

Regional Analysis

North America is projected to account for notable market share, reflecting the region's growing consumer preference for healthy and clean-label products featuring natural ingredients. This shift in consumer behavior aligns seamlessly with the intrinsic appeal of tagatose, known for its low-calorie and low-glycemic properties. Companies have achieved significant regulatory and food application milestones in both the United States and Canada. The advancement of commercial production facilities underscores the industry's commitment to advancing the use of tagatose, a rare sugar, in various food applications, positioning North America as a key market driver.

Product Specifications

Leading manufacturers and distributors provide high-quality tagatose products that consistently meet or exceed grade requirements and specifications. L-Tagatose products feature molecular formula C6H12O6 with molecular weight of 180.16, maintaining rigorous quality standards. D-Tagatose products, including specialized variants, boast high purity levels of 97-98%, adhering to stringent specifications and quality standards. These substances are characterized by specific molecular weights and formulas, with optimal storage conditions recommended in inert atmospheres at room temperature.

D-tagatose is available as white crystalline powder exhibiting specific boiling points and flash points, with defined density and predicted pKa values. Products are soluble in water and intended for various applications. Manufacturers provide comprehensive ranges of products and services, positioning themselves as trusted sources of research materials and fine chemicals in the scientific and food industry communities, supporting continued market development and application expansion.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Tagatose Market Segmentation

By Application

  • Food And Beverages
  • Pharmaceutical
  • Others

By Form

  • Powder
  • Liquid

By Distribution Channel

  • Online
  • Offline

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. TAGATOSE MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Food And Beverages
  • 5.3. Pharmaceutical
  • 5.4. Others

6. TAGATOSE MARKET BY FORM

  • 6.1. Introduction
  • 6.2. Powder
  • 6.3. Liquid

7. TAGATOSE MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Online
  • 7.3. Offline

8. TAGATOSE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Bonumose, Inc.
  • 10.2. Damhert Nutrition NV
  • 10.3. Linlu Biotechnology Co., Ltd.
  • 10.4. Anhui Hegeng Biotech Engineering
  • 10.5. Wuxi Jcantek Pharmaceuticals
  • 10.6. Syngars Technology
  • 10.7. Henan Yihengyuan Biotechnology
  • 10.8. Zhejiang Yixin Pharmaceutical Co., Ltd.
  • 10.9. Huaxu Pharmaceutical
  • 10.10. Glentham Life Sciences
  • 10.11. Clearsynth Labs
  • 10.12. GLR Innovations
  • 10.13. Inalco SpA
  • 10.14. HSF Biotech
  • 10.15. Hebei Runxuchen Trading Co., Ltd.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제